| 摘要 |
<p>The present invention provides a prodrug of the general formula FTLi-(PRT)m, where FTLi is a ras inhibitor such as a farnesyltransferase inhibitor compound and PRT represents m protecting groups capable of being cleaved from the ras inhibitor by the action of an enzyme, where m is an integer from 1 to 5.</p> |
